Speciality Medicines Ltd PE Ratio

Speciality Medicines PE Ratio

Image

Speciality Medicines Ltd

NSE: SPML

PE

30.6

Last updated on: May 11, 2026

Key Highlights

  • The P/E Ratio of Speciality Medicines Ltd is 30.6 as of 11 May 26 The P/E Ratio of Speciality Medicines Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Latest Trading Price of Speciality Medicines Ltd is ₹ 284.8 as of 12 May 15:30 The PE Ratio of Pharmaceuticals Industry has changed from 24.6 to 32.3 in 5 years. This represents a CAGR of 5.60% The PE Ratio of Automobile industry is 21.6. The PE Ratio of Finance industry is 18.8. The PE Ratio of IT - Software industry is 16.9. The PE Ratio of Pharmaceuticals industry is 32.3. The PE Ratio of Retail industry is 121.9. The PE Ratio of Textiles industry is 54.0 in 2025 .

Historical P/E Ratio of Speciality Medicines Ltd

No data available

Company Fundamentals for Speciality Medicines Ltd

Image

Speciality Medicines Ltd

NSE: SPML

Share Price

₹ 284.8

-14.95 (-4.99%)

stock direction

Last updated on: May 12, 2026

Market Price of Speciality Medicines Ltd

1M

1Y

3Y

5Y

Monitoring Speciality Medicines Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 May 2026299.75
08 May 2026315.5
07 May 2026332
06 May 2026316.2
05 May 2026301.15
04 May 2026313.95
30 Apr 2026330.45
29 Apr 2026347.8
28 Apr 2026363.05
27 Apr 2026345.8

BlinkX Score for Speciality Medicines Ltd

Asset Value vs Market Value of Speciality Medicines Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

PE Ratio of Speciality Medicines Ltd Explained

263.35

Market cap

8

Earnings

30.6X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Speciality Medicines Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Speciality Medicines Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Speciality Medicines Ltd

No data available

* All values are in %

About Speciality Medicines Ltd

  • Speciality Medicines Limited was originally incorporated as 'Speciality Medicines Private Limited' as a Private Limited Company, dated February 05, 2021, issued by the Registrar of Companies, Central Registration Centre.
  • Later on, the status was converted to Public Limited and the name of the Company was changed to 'Speciality Medicines Limited' and a fresh Certificate of Incorporation dated June 25, 2024 was issued to the Company by Registrar of Companies. The Company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market.
  • The Company has presence over 35 countries. The Company deal in Specialty pharmaceuticals finished formulations Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nasal Spray, Ointment, Ophthalmic, Oral Solution, Oral Suspension, Sachet, Suspension and Tablet.

Speciality Medicines Ltd News Hub

BSE SME Speciality Medicines debuts without fireworks

The scrip was listed at Rs 124, matching the initial public offer (IPO) price. The counter hit a hig

Read more

30 Mar 26

Sensex, Nifty trade with sharp losses; PSU Bank shares drop

The domestic equity benchmarks remained under pressure in mid-afternoon trade with sharp losses as i

Read more

23 Apr 26

Speciality Medicines inks commercial agreement valued at USD 2 million

Speciality Medicines has finalized a commercial arrangement with an international entity that specia

Read more

23 Apr 26

Speciality Medicines climbs after securing $2 million overseas order

The company said it has entered into a commercial arrangement with a global distributor for pharmace

Read more

23 Apr 26

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions